Aleksandra Filipovska
Aleksandra Filipovska is an Australian biochemist and molecular biologist. She is a professor, Deputy Director of the ARC Centre of Excellence in Synthetic Biology and NHMRC Investigator at the University of Western Australia, heading a research group at the Telethon Kids Institute.[1][2] Specializing in biochemistry and molecular biology, she has made contributions to the understanding of human mitochondrial genetics in health and disease.[3] Education and trainingAfter graduating with a Bachelor of Science (with Honors, 1st Class) in 1998, Filipovska received her Ph.D. at the University of Otago, New Zealand in 2002.[4] Between 2003-2005 she completed postdoctoral training as a New Zealand Foundation for Research, Science and Technology Fellow at the MRC Mitochondrial Biology Unit in Cambridge, the United Kingdom, before relocating to Australia in 2006 as a National Health and Medical Research Council of Australia (NHMRC) Howard Florey Fellow. From 2009-2014, she was an Australian Research Council (ARC) Future Fellow. She has been supported by an NHMRC Senior Research Fellowship from 2014 to 2024 and an NHMRC Investigator Grant since 2024 as well as project grants from the NHMRC and ARC.[5][6] Research focusFilipovska's research focuses on mitochondria, the 'powerhouses' that provide all human cells with energy. Dysfunction of mitochondria contributes to a variety of debilitating human diseases including neurodegenerative, cardiovascular and metabolic disorders, as well as cancer. During her graduate studies, Filipovska investigated how mutations in genes encoding for mitochondrial proteins can lead to disease, and developed new approaches to manipulate mitochondrial DNA replication and expression as potential therapies.[3][6] During her postdoctoral work, she explored the use of compounds targeting mitochondria as a means to reduce oxidative stress in cells during aging and disease.[6] Since establishing her research group at the Harry Perkins Institute of Medical Research and Telethon Kids Institute, Filipovska has continued to focus on molecular mechanisms that govern mitochondrial gene expression and protein synthesis and how defects in these processes can cause disease. Awards and prizesFilipovska has been awarded the:
She was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2022.[9] References
|